drug rehab centers washington

Sequester Threat to Domestic Programs Drowned Out by Defense Cries – Scalia

Sequester threat to domestic programs drowned out by defense cries – Scalia

Filed under: Drug Rehab Centers Washington D.C.

Not to mention 12150 fewer patients with access to AIDS Drug Assistance Program benefits and 169000 people who would not… Continue reading

Alnylam Gets Orphan Drug Status for Potential Treatment for Rare

Alnylam gets orphan drug status for potential treatment for rare

Filed under: Drug Rehab Centers Washington D.C.

Alnylam Pharmaceuticals Inc. said Tuesday that it received special regulatory incentives for a drug designed to treat a potentially fatal neurodegenerative …… Continue reading

Louisiana Legislature Takes Steps Toward Reducing Incarceration for Nonviolent

Louisiana Legislature takes steps toward reducing incarceration for nonviolent

Filed under: Drug Rehab Centers Washington D.C.

Enlarge Scott Threlkeld, The Times-Picayune SCOTT THRELKELD / THE TIMES-PICAYUNE Inmates return to their dormitory from the cafeteria at Richland Parish Detention Center… Continue reading

Fiscal Year 2013 Executive Budget Hearing

Fiscal Year 2013 Executive Budget Hearing

Filed under: Drug Rehab Centers Washington D.C.

Developmental evaluation services are currently provided at Morrisania Diagnostic & Treatment Center , Renaissance Diagnostic & Treatment Center , Kings County Hospital Center and Queens Hospital Center.… Continue reading

This Week in Poverty: Wage Theft in the City of Millionaires

This Week in Poverty: Wage Theft in the City of Millionaires

Filed under: Drug Rehab Centers Washington D.C.

Convicted of a drug-related offense? No TANF for you. The Western Center on Law and Poverty sponsored a bill that would have… Continue reading

UPDATED: ASCO Abstracts Reveal Added Appeal for Key Cancer Drug Prospects

UPDATED: ASCO abstracts reveal added appeal for key cancer drug prospects

Filed under: Drug Rehab Centers Washington D.C.

That's the real potential value of tivozanib," Dr. Michael Atkins, a TIVO-1 study investigator and deputy director of the Georgetown Lombardi Comprehensive… Continue reading